4//SEC Filing
EASTLAND JULIA MARIE 4
Accession 0001209191-23-056805
CIK 0001708493other
Filed
Nov 27, 7:00 PM ET
Accepted
Nov 28, 4:30 PM ET
Size
8.9 KB
Accession
0001209191-23-056805
Insider Transaction Report
Form 4
EASTLAND JULIA MARIE
Director
Transactions
- Award
Common Stock
2023-11-26+50,000→ 53,503 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock, issuable upon the vesting and settlement of RSUs.
- [F2]25% of the RSUs will vest on each May 26th and November 26th of 2024 and 2025, subject to acceleration and vesting in full upon a Change in Control (as defined in the Issuer's 2019 Equity Incentive Plan) of the Issuer, and subject to the continuing employment of the Reporting Person on each vesting date.
- [F3]Includes 500 shares acquired under the Issuer's employee stock purchase plan on September 30, 2022, 750 shares acquired on March 31, 2023, and 2,253 shares acquired on September 29, 2023.
- [F4]Shares reflect 1:10 reverse stock split effective September 1, 2023.
Documents
Issuer
Harpoon Therapeutics, Inc.
CIK 0001708493
Entity typeother
Related Parties
1- filerCIK 0001500189
Filing Metadata
- Form type
- 4
- Filed
- Nov 27, 7:00 PM ET
- Accepted
- Nov 28, 4:30 PM ET
- Size
- 8.9 KB